Your browser is no longer supported. Please, upgrade your browser.
EBS [NYSE]
Emergent BioSolutions Inc.
Index- P/E12.06 EPS (ttm)5.63 Insider Own2.70% Shs Outstand53.30M Perf Week-10.53%
Market Cap3.49B Forward P/E12.68 EPS next Y5.35 Insider Trans-13.33% Shs Float45.20M Perf Month-23.13%
Income305.10M PEG1.31 EPS next Q1.15 Inst Own84.10% Short Float5.75% Perf Quarter-36.15%
Sales1.56B P/S2.24 EPS this Y445.20% Inst Trans2.89% Short Ratio3.55 Perf Half Y-31.82%
Book/sh27.15 P/B2.50 EPS next Y-42.28% ROA11.90% Target Price113.86 Perf Year1.06%
Cash/sh12.09 P/C5.61 EPS next 5Y9.20% ROE24.50% 52W Range64.04 - 137.61 Perf YTD-24.25%
Dividend- P/FCF8.83 EPS past 5Y24.00% ROI14.30% 52W High-50.68% Beta1.07
Dividend %- Quick Ratio2.30 Sales past 5Y26.00% Gross Margin67.40% 52W Low5.98% ATR4.07
Employees2200 Current Ratio3.10 Sales Q/Q61.80% Oper. Margin27.90% RSI (14)28.96 Volatility5.27% 4.31%
OptionableYes Debt/Eq0.60 EPS Q/Q283.00% Profit Margin19.60% Rel Volume2.24 Prev Close77.64
ShortableYes LT Debt/Eq0.58 EarningsApr 29 AMC Payout0.00% Avg Volume732.63K Price67.87
Recom2.00 SMA20-19.34% SMA50-28.81% SMA200-31.68% Volume1,603,844 Change-12.58%
Apr-07-21Initiated The Benchmark Company Buy $150
Feb-24-21Upgrade Chardan Capital Markets Neutral → Buy $112
Feb-19-21Downgrade Chardan Capital Markets Buy → Neutral $112
Jan-08-21Downgrade Wells Fargo Overweight → Equal Weight $110
Sep-14-20Resumed JP Morgan Neutral $103
Jul-31-20Reiterated Chardan Capital Markets Buy $86 → $112
Sep-12-19Initiated Guggenheim Buy
Sep-04-19Upgrade Wells Fargo Market Perform → Outperform
Nov-02-18Upgrade Goldman Neutral → Buy
Aug-03-18Reiterated Chardan Capital Markets Buy $53 → $57
Jun-13-18Initiated Argus Buy $62
Apr-25-18Downgrade Wells Fargo Outperform → Market Perform
Jan-24-18Initiated Goldman Neutral
Jan-16-18Reiterated Chardan Capital Markets Buy $47 → $53
Jun-28-16Reiterated Singular Research Buy $44 → $40
Apr-15-16Initiated Chardan Capital Markets Buy $47
Mar-28-16Initiated Singular Research Buy $44
Feb-19-16Initiated Wells Fargo Outperform
May-15-14Initiated Summer Street Research Buy $35
May-31-11Reiterated WBB Securities Strong Buy $20.50 → $30
Apr-19-21 10:45PM  
06:19PM  
02:21PM  
01:20PM  
12:39PM  
12:29PM  
06:42AM  
06:42AM  
05:45AM  
Apr-16-21 11:30PM  
Apr-15-21 06:30AM  
Apr-14-21 10:48PM  
Apr-13-21 03:35PM  
07:05AM  
Apr-12-21 09:00PM  
Apr-10-21 08:01PM  
Apr-09-21 11:51AM  
Apr-08-21 11:51AM  
10:45AM  
09:41AM  
Apr-07-21 04:34PM  
03:13PM  
Apr-06-21 06:51PM  
05:15AM  
04:14AM  
Apr-05-21 07:51PM  
01:33PM  
11:28AM  
11:00AM  
10:42AM  
10:13AM  
07:14AM  
07:05AM  
06:58AM  
05:56AM  
04:47AM  
Apr-04-21 10:54PM  
10:09PM  
01:32PM  
Apr-02-21 09:51AM  
08:00AM  
Apr-01-21 06:56PM  
10:35AM  
08:36AM  
08:12AM  
05:51AM  
05:26AM  
Mar-31-21 08:00PM  
06:56PM  
06:52PM  
Mar-25-21 01:24PM  
Mar-23-21 02:32PM  
Mar-20-21 11:30AM  
Mar-15-21 04:08PM  
Mar-11-21 03:38PM  
Mar-09-21 11:34AM  
06:25AM  
Mar-08-21 10:55AM  
Mar-04-21 11:57AM  
06:08AM  
03:27AM  
Mar-02-21 03:41AM  
Mar-01-21 06:30AM  
Feb-25-21 07:00AM  
Feb-24-21 10:07AM  
Feb-19-21 11:27AM  
10:57AM  
04:01AM  
Feb-18-21 04:45PM  
04:38PM  
04:25PM  
04:05PM  
03:15PM  
Feb-17-21 12:44PM  
Feb-15-21 12:00AM  
Feb-11-21 06:14AM  
Feb-10-21 01:40PM  
Feb-04-21 02:37PM  
01:54PM  
06:30AM  
Feb-03-21 12:08PM  
Feb-01-21 02:57PM  
01:45PM  
Jan-27-21 01:06PM  
12:45PM  
Jan-26-21 03:39PM  
Jan-25-21 02:20PM  
01:21PM  
08:30AM  
Jan-20-21 12:45PM  
Jan-13-21 01:38PM  
Jan-12-21 10:37AM  
Jan-11-21 09:22AM  
09:15AM  
Jan-10-21 02:00PM  
Jan-07-21 12:45PM  
Jan-06-21 05:50PM  
11:30AM  
Jan-05-21 07:03AM  
Jan-04-21 03:25PM  
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response products and solutions for civilian and military populations that address accidental, deliberate, and naturally occurring public health threats (PHTs). The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emerging infectious diseases; travel health; and emerging health crises and acute/emergency care. It offers ACAM2000, a smallpox vaccine; BioThrax, an anthrax vaccine; Vaxchora, a cholera vaccine; and Vivotif, a typhoid vaccine. The company also provides NARCAN for the emergency treatment of known or suspected opioid overdose; and Reactive Skin Decontamination Lotion Kit, a medical device to remove or neutralize chemical warfare agents from the skin. In addition, it offers raxibacumab for the treatment and prophylaxis of inhalational anthrax; Anthrasil to treat inhalational anthrax; Botulism Antitoxin Heptavalent for treating botulinum disease; vaccinia immune globulin intravenous that addresses complications from smallpox vaccination; and Trobigard a combination drug-device auto injector product candidate. Further, the company is developing COVID-EIG and COVID-HIG potential treatments to COVID-19 disease; and FLU-IGIV for the treatment of Influenza A infection in hospitalized patients. Additionally, it provides contract development and manufacturing service that comprises development services, drug substance manufacturing, and drug product manufacturing in the pharmaceutical and biotechnology industries, as well as the governments and non-governmental organizations. The company has collaboration agreements with Novavax Inc.; and Johnson & Johnson. Emergent BioSolutions Inc. was founded in 1998 and is headquartered in Gaithersburg, Maryland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bailey SueDirectorMar 04Sale92.378,168754,47824,427Mar 08 06:30 PM
Havey AdamEVP, Business OperationsMar 01Option Exercise40.9037,2791,524,81258,335Mar 03 06:07 PM
Havey AdamEVP, Business OperationsMar 01Sale99.3037,2793,701,64738,190Mar 03 06:07 PM
Kramer RobertPresident and CEOFeb 08Option Exercise30.7945,3971,397,961171,607Feb 09 05:23 PM
Kramer RobertPresident and CEOFeb 08Sale120.0345,3975,449,002139,210Feb 09 05:23 PM
Kramer RobertPresident and CEOJan 21Option Exercise26.4521,900579,255161,110Jan 22 04:14 PM
Kramer RobertPresident and CEOJan 21Sale110.0321,9002,409,657139,210Jan 22 04:14 PM
Kramer RobertPresident and CEOJan 20Option Exercise26.452,23259,036141,442Jan 22 04:14 PM
Kramer RobertPresident and CEOJan 20Sale110.002,232245,520139,210Jan 22 04:14 PM
Kramer RobertPresident and CEOJan 15Option Exercise25.6219,026487,446158,236Jan 19 04:28 PM
Kramer RobertPresident and CEOJan 15Sale106.0119,0262,016,901139,210Jan 19 04:28 PM
El-Hibri FuadChairmanNov 10Option Exercise26.4519,391512,8921,143,379Nov 12 06:30 PM
El-Hibri FuadChairmanNov 10Sale88.2119,3911,710,4801,123,988Nov 12 06:30 PM
El-Hibri FuadChairmanNov 09Option Exercise26.4520,000529,0001,143,988Nov 12 06:30 PM
El-Hibri FuadChairmanNov 09Sale95.2620,0001,905,2001,123,988Nov 12 06:30 PM
El-Hibri FuadChairmanNov 03Option Exercise26.4520,000529,0001,143,988Nov 04 08:53 PM
El-Hibri FuadChairmanNov 03Sale90.7420,0001,814,8001,123,988Nov 04 08:53 PM
El-Hibri FuadChairmanNov 02Option Exercise26.4520,000529,0001,143,988Nov 04 08:53 PM
El-Hibri FuadChairmanNov 02Sale90.4420,0001,808,8001,123,988Nov 04 08:53 PM
El-Hibri FuadChairmanSep 24Sale98.8512,5351,239,0851,123,988Sep 25 07:00 PM
El-Hibri FuadChairmanSep 23Sale100.5813,0001,307,5401,136,523Sep 25 07:00 PM
El-Hibri FuadChairmanSep 17Sale100.6820,0002,013,6001,149,523Sep 18 06:25 PM
El-Hibri FuadChairmanSep 16Sale102.4820,0002,049,6001,169,523Sep 18 06:25 PM
El-Hibri FuadChairmanSep 10Sale102.6620,0002,053,2001,189,523Sep 11 09:21 PM
El-Hibri FuadChairmanSep 09Sale102.8020,0002,056,0001,209,523Sep 11 09:21 PM
SULLIVAN LOUIS WDirectorSep 02Option Exercise20.087,893158,49150,655Sep 04 08:08 PM
SULLIVAN LOUIS WDirectorSep 02Sale111.2228,4183,160,60642,762Sep 04 08:08 PM
Bailey SueDirectorAug 18Sale128.314,665598,56432,595Aug 19 05:08 PM
Harsanyi ZsoltDirectorAug 17Sale133.716,609883,66424,579Aug 18 09:12 AM
JOULWAN GEORGE ADirectorAug 11Sale124.116,000744,63526,771Aug 12 04:52 PM
Zoon Kathryn CDirectorAug 10Sale130.271,000130,27012,489Aug 11 04:43 PM
Richard RonaldDirectorAug 07Sale131.006,297824,9078,276Aug 11 04:46 PM
Richard RonaldDirectorJun 03Sale87.516,572575,1424,269Jun 05 04:36 PM
Bailey SueDirectorJun 03Sale87.505,322465,69137,260Jun 05 04:33 PM
Hauer Jerome MDirectorMay 26Sale85.154,385373,37310,188May 27 05:10 PM
Zoon Kathryn CDirectorMay 26Sale85.104,093348,32213,489May 27 05:07 PM
Harsanyi ZsoltDirectorMay 14Option Exercise18.643,43464,01028,367May 18 07:12 PM
Zoon Kathryn CDirectorMay 12Sale85.211,660141,45414,761May 14 04:30 PM
Harsanyi ZsoltDirectorMay 11Sale81.994,940405,02524,933May 13 07:47 PM
JOULWAN GEORGE ADirectorMay 11Sale85.192,000170,37129,950May 13 07:45 PM
Richard RonaldDirectorMay 05Sale80.198,375671,6298,020May 06 05:08 PM
El-Hibri FuadChairmanApr 30Sale74.0120,0001,480,2001,229,523May 01 08:13 PM
El-Hibri FuadChairmanApr 29Sale74.2420,0001,484,8001,249,523May 01 08:13 PM
Richard RonaldDirectorApr 27Option Exercise20.087,893158,49124,288Apr 29 04:35 PM
Richard RonaldDirectorApr 27Sale78.007,893615,65416,395Apr 29 04:35 PM
El-Hibri FuadChairmanApr 23Sale68.4920,0001,369,8001,269,523Apr 24 04:16 PM
El-Hibri FuadChairmanApr 22Sale66.8120,0001,336,2001,289,523Apr 24 04:16 PM